Search Results - Richard Nicholas

Refine Results
  1. 1

    Increased health utilisation before MS diagnosis: evidence from the SAIL Databank by James Witts, Rodden Middleton, Richard Nicholas

    Get full text
    Article


  2. 2

    Changing EDSS Progression in Placebo Cohorts in Relapsing MS: A Systematic Review and Meta-Regression. by Christian Röver, Richard Nicholas, Sebastian Straube, Tim Friede

    Published in PLoS ONE (2015-01-01)
    Get full text
    Article


  3. 3

    Sequential strokes in a hyperacute stroke unit by Jeban Ganesalingam, Sandeep Buddha, Anoma L Carlton-Jones, Richard Nicholas

    Published in JRSM Open (2014-07-01)
    Get full text
    Article


  4. 4

    Free serum haemoglobin is associated with brain atrophy in secondary progressive multiple sclerosis [version 1; referees: 1 approved, 2 approved with reservations] by Alex Lewin, Shea Hamilton, Aviva Witkover, Paul Langford, Richard Nicholas, Jeremy Chataway, Charles R.M. Bangham

    Published in Wellcome Open Research (2016-11-01)
    Get full text
    Article


  5. 5

    Free serum haemoglobin is associated with brain atrophy in secondary progressive multiple sclerosis [version 2; referees: 1 approved, 2 approved with reservations] by Alex Lewin, Shea Hamilton, Aviva Witkover, Paul Langford, Richard Nicholas, Jeremy Chataway, Charles R.M. Bangham

    Published in Wellcome Open Research (2016-12-01)
    Get full text
    Article


  6. 6

    El plan maestro de producción y la incertidumbre en el sector manufactura: una revisión de la literatura by Gustavo Adolfo Luna-Victoria-León, Martín Fidel Collao-Díaz, Jorge Antonio Corzo-Chávez, Richard Nicholas Meza-Ortiz

    Published in Ingeniería Industrial (2022-12-01)
    Get full text
    Article


  7. 7

    "I wanna live and not think about the future" what place for advance care planning for people living with severe multiple sclerosis and their families? A qualitative study. by Jonathan Koffman, Clarissa Penfold, Laura Cottrell, Bobbie Farsides, Catherine J Evans, Rachel Burman, Richard Nicholas, Stephen Ashford, Eli Silber

    Published in PLoS ONE (2022-01-01)
    Get full text
    Article


  8. 8

    Worse Physical Disability Is Associated With the Expression of PD-1 on Inflammatory T-Cells in Multiple Sclerosis Patients With Older Appearing Brains by Sophie A. H. Jacobs, Sophie A. H. Jacobs, Paolo A. Muraro, Paolo A. Muraro, Maria T. Cencioni, Sarah Knowles, James H. Cole, Richard Nicholas

    Published in Frontiers in Neurology (2022-01-01)
    Get full text
    Article


  9. 9

    Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations by Alexander Stahmann, Elaine Craig, David Ellenberger, Firas Fneish, Niklas Frahm, Ruth Ann Marrie, Rod Middleton, Richard Nicholas, Jeff Rodgers, Clemens Warnke, Amber Salter

    Get full text
    Article


  10. 10

    Carbon dioxide flushing versus saline flushing of thoracic aortic stents (INTERCEPTevar): protocol for a multicentre pilot randomised controlled trial by Abhinav Singh, Bijan Modarai, Richard Gibbs, Stephen Crockett, Oliver Lyons, Richard Nicholas, Colin Bicknell, Stephen Gunning, Lydia Hanna, Mohamad Hamady, Dennis Gable, Morad Sallam, Said Abisi

    Published in BMJ Open (2023-04-01)
    Get full text
    Article


  11. 11

    Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis by Roberta Magliozzi, Simon Hametner, Francesco Facchiano, Damiano Marastoni, Stefania Rossi, Marco Castellaro, Alberto Poli, Federico Lattanzi, Andrea Visconti, Richard Nicholas, Richard Reynolds, Salvatore Monaco, Hans Lassmann, Massimiliano Calabrese

    Get full text
    Article


  12. 12

    Algorithmic Identification of Multiple Sclerosis  in the SAIL databank by Rod Middleton, Richard Nicholas, Emma Tallantyre, James Witts, Ruth Ann Marrie, Elaine Craig, Sarah Knowles, Owen Pearson, Katherine Harding, Karim Kreft, Jonathon Hawken, Gillian Ingram, Bethan Morgan, Neil Robertson

    Get full text
    Article


  13. 13

    Large-scale online assessment uncovers a distinct Multiple Sclerosis subtype with selective cognitive impairment by Annalaura Lerede, Alexandra Moura, Valentina Giunchiglia, Elisa Carta, William Trender, Katherine Tuite-Dalton, James Witts, Elaine Craig, Sarah Knowles, Jeff Rodgers, Eleonora Cocco, Peter J. Hellyer, Rod Middleton, Richard Nicholas, Adam Hampshire

    Published in Nature Communications (2025-09-01)
    Get full text
    Article


  14. 14

    Analysis of ageing-associated grey matter volume in patients with multiple sclerosis shows excess atrophy in subcortical regions by Courtney A Bishop, Rexford D Newbould, Jean SZ Lee, Lesley Honeyfield, Rebecca Quest, Alessandro Colasanti, Rehiana Ali, Miriam Mattoscio, Antonio Cortese, Richard Nicholas, Paul M. Matthews, Paolo A Muraro, Adam D Waldman

    Published in NeuroImage: Clinical (2017-01-01)
    Get full text
    Article


  15. 15

    OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis by Ana Cavey, Ruth Dobson, Camilla Blain, Richard Nicholas, Jeremy Hobart, David Rog, Monica Marta, Cheryl Hemingway, Nikos Evangelou, Matthew Craner, Paul M Matthews, Neil Scolding, Helen L Ford, Stewart Webb, Ed Waddingham, Aleisha Miller, Carolyn Anne Young

    Published in BMJ Open (2021-11-01)
    Get full text
    Article


  16. 16

    Soluble CD27 is an intrathecal biomarker of T-cell-mediated lesion activity in multiple sclerosis by Maria T. Cencioni, Roberta Magliozzi, Ilaria Palmisano, Keittisak Suwan, Antonella Mensi, Laura Fuentes-Font, Luisa M. Villar, José I. Fernández-Velasco, Noelia Villarrubia Migallón, Lucienne Costa-Frossard, Enric Monreal, Rehiana Ali, Marina Romozzi, Nicholas Mazarakis, Richard Reynolds, Richard Nicholas, Paolo A. Muraro

    Published in Journal of Neuroinflammation (2024-04-01)
    Get full text
    Article


  17. 17

    The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries ac... by Richard Nicholas, Jeff Rodgers, James Witts, Annalaura Lerede, Tim Friede, Jan Hillert, Lars Forsberg, Anna Glaser, Ali Manouchehrinia, Ryan Ramanujam, Tim Spelman, Pernilla Klyve, Jiri Drahota, Dana Horakova, Hanna Joensen, Luigi Pontieri, Melinda Magyari, David Ellenberger, Alexander Stahmann, Helmut Butzkueven, Anneke Van Der Walt, Vladimir Bezlyak, Carol Lines, Rod Middleton

    Get full text
    Article


  18. 18

    Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers by Lars Forsberg, Tim Spelman, Pernilla Klyve, Ali Manouchehrinia, Ryan Ramanujam, Elena Mouresan, Jiri Drahota, Dana Horakova, Hanna Joensen, Luigi Pontieri, Melinda Magyari, David Ellenberger, Alexander Stahmann, Jeff Rodgers, James Witts, Rod Middleton, Richard Nicholas, Vladimir Bezlyak, Nicholas Adlard, Thomas Hach, Carol Lines, Sandra Vukusic, Merja Soilu-Hänninen, Anneke van der Walt, Helmut Butzkueven, Pietro Iaffaldano, Maria Trojano, Anna Glaser, Jan Hillert

    Get full text
    Article


  19. 19

    Brain reserve and physical disability in secondary progressive multiple sclerosis by Nevin John, Jeremy Chataway, Jacqueline Palace, Gavin Giovannoni, David Paling, Frederik Barkhof, Floriana De Angelis, Lorraine Smith, Thomas Williams, Martin Duddy, James Overell, Basil Sharrack, Sebastien Ourselin, Allan Walker, Siddharthan Chandran, Richard Nicholas, Shuna Colville, Peter Connick, Carolyn Young, Jeremy Hobart, Anisha Doshi, Sharmilee Gnanapavan, Helen Ford, Baljean Dhillon, Thanh Phan, Arman Eshaghi, Julia Aram, Nigel Stallard, James Cameron, Brendan McLean, Matthew Craner, Domenico Plantone, Jonathan Stutters, Ferran Prados Carrasco, Marie Braisher, Moira Ross, Gina Cranswick, Sue H Pavitt, Clive Hawkins, Roger Bastow, Daisy Mollison, Waqar Rashid, Joe Guadagno, Nikolaos Evangelou, Seema Kalra, Alberto Calvi, Yingtong Li, Tiggy Beyene, Vanessa Bassan, Alvin Zapata, Dawn Lyle, Heinke Arndt

    Published in BMJ Neurology Open (2024-09-01)
    Get full text
    Article


  20. 20

    Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (Star... by Gavin Giovannoni, Stephen J Walters, David Paling, Olga Ciccarelli, Cindy Cooper, Eli Silber, Martin Duddy, Hannah Hunter, David Hunt, Basil Sharrack, Paul Gallagher, Ian Galea, Richard Nicholas, Annalena Venneri, Neil Robertson, Carolyn Young, Jeremy Hobart, David Rog, Ben Turner, Muhammad Saif, Azza Ismail, Gavin Brittain, John A Snowden, Diana Papaioannou, Alasdair J Coles, Gordon Mazibrada, Neil Scolding, Maruthi Vinjam, Matthew Bursnall, Claire Rice, Ian Pomeroy, Majid Kazmi, Esmaeil Nikfekr, Kim Orchard, Thushan de Silva, Jennifer Petrie, Elisa Roldan, Caroline Besley, Kate E M Duffy, Rachel Glover, Katie Hullock, Colette Beecher, Ian Gabriel, Charalampia Kyriakou, Andy Peniket, Paolo A Muraro, Amy Publicover, Andy Clark, Charles Crawley, Eleni Tholouli, Fran Kinsella, Gabriele De Luca, Jeff Davies, Jenny Byrne, Keith Campbell, Leonora Finisku, Simon Bulley, Vic Campbell

    Published in BMJ Open (2024-02-01)
    Get full text
    Article


Search Tools: